SIPPET Study results were published on May 26 by the prestigious “New England Journal of Medicine”.
SIPPET is the first randomized controlled multicenter study on hemophilia A and inhibitors development that answers the key clinical question on the role of the factor VIII product source. This investigator-initiated clinical study involved 42 hemophilia treatment centers from all over the world. The study was sponsored by the Angelo Bianchi Bonomi Foundation, with financial support from the Italian Ministry of Health and unrestricted grants from Grifols, Kedrion and LFB.
New England Journal of Medicine: http://www.nejm.org